Zhili Rong

4.8k total citations · 3 hit papers
55 papers, 3.1k citations indexed

About

Zhili Rong is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhili Rong has authored 55 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhili Rong's work include CRISPR and Genetic Engineering (17 papers), RNA Interference and Gene Delivery (8 papers) and Pluripotent Stem Cells Research (7 papers). Zhili Rong is often cited by papers focused on CRISPR and Genetic Engineering (17 papers), RNA Interference and Gene Delivery (8 papers) and Pluripotent Stem Cells Research (7 papers). Zhili Rong collaborates with scholars based in China, United States and Canada. Zhili Rong's co-authors include Yang Xu, Zhen‐Ning Zhang, Tongbiao Zhao, Ying Lin, Meiyan Wang, Bin Yang, Zhijie Chang, Yongfei Hu, Cheng‐Cheng Deng and Yingping Xu and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Zhili Rong

52 papers receiving 3.0k citations

Hit Papers

Immunogenicity of induced pluripotent stem cells 2011 2026 2016 2021 2011 2021 2021 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunogenicity of induced pluripotent stem cells
    2011 1.0k citations Zhili Rong et al. profile →
  2. Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases
    2021 280 citations Cheng‐Cheng Deng, Yongfei Hu et al. Nature Communications profile →
  3. A Biomimetic Drug Delivery System by Integrating Grapefruit Extracellular Vesicles and Doxorubicin-Loaded Heparin-Based Nanoparticles for Glioma Therapy
    2021 258 citations Wenbo Niu, Qian Xiao et al. Nano Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhili Rong China 23 2.0k 632 418 367 330 55 3.1k
Patrizia Dell’Era Italy 31 2.7k 1.3× 434 0.7× 329 0.8× 306 0.8× 445 1.3× 69 4.1k
Il Ho Jang South Korea 28 1.7k 0.8× 276 0.4× 374 0.9× 367 1.0× 334 1.0× 62 2.8k
Valeria V. Orlova Netherlands 31 1.9k 1.0× 807 1.3× 681 1.6× 1.0k 2.8× 321 1.0× 77 3.8k
Régis Doyonnas United States 23 1.7k 0.9× 559 0.9× 483 1.2× 268 0.7× 496 1.5× 37 3.0k
Yun Bai China 27 1.4k 0.7× 218 0.3× 337 0.8× 302 0.8× 329 1.0× 89 2.3k
Nathalie Rochet France 30 894 0.4× 547 0.9× 247 0.6× 497 1.4× 415 1.3× 95 2.5k
Tiziano Barberi United States 19 2.5k 1.2× 622 1.0× 314 0.8× 344 0.9× 184 0.6× 33 3.3k
Monique M.A. Verstegen Netherlands 31 1.0k 0.5× 753 1.2× 292 0.7× 477 1.3× 677 2.1× 87 2.8k
Sebastian Diecke Germany 30 2.6k 1.3× 872 1.4× 145 0.3× 844 2.3× 256 0.8× 68 3.7k
Heather Whetstone Canada 23 1.5k 0.7× 276 0.4× 284 0.7× 217 0.6× 429 1.3× 32 2.6k

Countries citing papers authored by Zhili Rong

Since Specialization
Citations

This map shows the geographic impact of Zhili Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhili Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhili Rong more than expected).

Fields of papers citing papers by Zhili Rong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhili Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhili Rong. The network helps show where Zhili Rong may publish in the future.

Co-authorship network of co-authors of Zhili Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhili Rong. A scholar is included among the top collaborators of Zhili Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhili Rong. Zhili Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rong, Zhili, et al.. (2025). A novel distributed-order time fractional derivative model of laser-induced thermal therapy for deep-lying tumor. Computers & Mathematics with Applications. 184. 107–115.
2.
Zhang, Xin, Yu‐Chen Liu, Jiawei Liu, et al.. (2025). Engineered circular guide RNAs enhance miniature CRISPR/Cas12f-based gene activation and adenine base editing. Nature Communications. 16(1). 3016–3016. 8 indexed citations
3.
4.
Li, Lian, Yuchen Liu, Shanshan Zhao, et al.. (2025). Human Pluripotent Stem Cell-Derived Alveolar Organoids for Gene-editing and Lung Adenocarcinomas Modeling. International Journal of Biological Sciences. 21(14). 6285–6304.
5.
Gu, Jingjing, Cheng‐Cheng Deng, Qing An, et al.. (2025). Lactate Promotes Collagen Expression, Proliferation, and Migration through H3K18 Lactylation–Dependent Stimulation of LTBP3/TGF-β1 Axis in Keloid Fibroblasts. Journal of Investigative Dermatology. 146(2). 522–534.e8. 2 indexed citations
6.
Liang, Yunsheng, Yongfei Hu, Jun Zhang, et al.. (2024). Dynamic pathological analysis reveals a protective role against skin fibrosis for TREM2-dependent macrophages. Theranostics. 14(5). 2232–2245. 9 indexed citations
7.
Gu, Jingjing, Cheng‐Cheng Deng, Jun Liu, et al.. (2023). Relief of Extracellular Matrix Deposition Repression by Downregulation of IRF1-Mediated TWEAK/Fn14 Signaling in Keloids. Journal of Investigative Dermatology. 143(7). 1208–1219.e6. 7 indexed citations
8.
Lv, Jie, Hongxin Huang, Jiahong Wang, et al.. (2023). Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing. Genome biology. 24(1). 145–145. 17 indexed citations
9.
Ma, Shufeng, Jie Lv, Hongxin Huang, et al.. (2023). Phase-separated DropCRISPRa platform for efficient gene activation in mammalian cells and mice. Nucleic Acids Research. 51(10). 5271–5284. 18 indexed citations
10.
11.
Niu, Wenbo, Qian Xiao, Xuejiao Wang, et al.. (2021). A Biomimetic Drug Delivery System by Integrating Grapefruit Extracellular Vesicles and Doxorubicin-Loaded Heparin-Based Nanoparticles for Glioma Therapy. Nano Letters. 21(3). 1484–1492. 258 indexed citations breakdown →
12.
Li, Lian, et al.. (2021). SOX9 inactivation affects the proliferation and differentiation of human lung organoids. Stem Cell Research & Therapy. 12(1). 343–343. 26 indexed citations
13.
Yang, Jieyi, Jun Zhang, Wujian Ke, et al.. (2020). MicroRNA-101-3p Downregulates TLR2 Expression, Leading to Reduction in Cytokine Production by Treponema pallidum–Stimulated Macrophages. Journal of Investigative Dermatology. 140(8). 1566–1575.e1. 22 indexed citations
14.
Pei, Rongjuan, Yecheng Zhang, Hao Sun, et al.. (2020). Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection. Protein & Cell. 12(9). 717–733. 76 indexed citations
15.
Xue, Yaohua, Wentao Chen, Xueying Yu, et al.. (2020). Inhibition of the Extracellular Signal–Regulated Kinase/Ribosomal S6 Kinase Cascade Limits Chlamydia trachomatis Infection. Journal of Investigative Dermatology. 141(4). 852–862.e6. 4 indexed citations
16.
17.
Chen, Yong, et al.. (2018). Long-Term Engraftment Promotes Differentiation of Alveolar Epithelial Cells from Human Embryonic Stem Cell Derived Lung Organoids. Stem Cells and Development. 27(19). 1339–1349. 31 indexed citations
18.
Li, Yinghua, Shan Zhong, Zhili Rong, et al.. (2007). The carboxyl terminal tyrosine 417 residue of NOK has an autoinhibitory effect on NOK-mediated signaling transductions. Biochemical and Biophysical Research Communications. 356(2). 444–449. 8 indexed citations
19.
Ren, Yongming, Long Cheng, Zhili Rong, et al.. (2007). hSef potentiates EGF-mediated MAPK signaling through affecting EGFR trafficking and degradation. Cellular Signalling. 20(3). 518–533. 29 indexed citations
20.
Rong, Zhili, Yongming Ren, Long Cheng, et al.. (2006). Sef-S, an alternative splice isoform of sef gene, inhibits NIH3T3 cell proliferation via a mitogen-activated protein kinases p42 and p44 (ERK1/2)-independent mechanism. Cellular Signalling. 19(1). 93–102. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizia Dell’Era Breakdown of academic impact, for papers by Il Ho Jang Breakdown of academic impact, for papers by Valeria V. Orlova Breakdown of academic impact, for papers by Régis Doyonnas Breakdown of academic impact, for papers by Yun Bai Breakdown of academic impact, for papers by Nathalie Rochet Breakdown of academic impact, for papers by Tiziano Barberi Breakdown of academic impact, for papers by Monique M.A. Verstegen Breakdown of academic impact, for papers by Sebastian Diecke Breakdown of academic impact, for papers by Heather Whetstone
Rankless by CCL
2026